Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women
T-CAFE
1 other identifier
interventional
102
1 country
1
Brief Summary
France is the country of Europe where the prevalence of pregnant women smokers is the highest (35.9% before pregnancy and in the 3rd quarter 21.8% in 2008). In the investigator's country, among the smokers of early pregnancy with the usual care, only 30% manage to stop during pregnancy. Maternal smoking during pregnancy is a clearly identified risk factor for the course of pregnancy and the unborn child. The measurement of carbon monoxide (CO) expired in pregnancy monitoring consultation is part of the recommendations of the consensus conference "Pregnancy and Tobacco" (ANAES, October 2004) and the parliamentary report on smoking by JL Touraine and D. Jacquat (Feb 2012). However, this recommendation has not entered the current practice. The research aims to justify the clinical relevance of this recommendation by demonstrating the positive impact of expired CO measurement on the rate of discontinuation during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedStudy Start
First participant enrolled
March 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2022
CompletedMarch 17, 2021
March 1, 2021
3 years
January 25, 2019
March 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Smoking cessation on the date of birth
Evaluate the impact on maternal smoking cessation rate at birth of a strategy combining maternal expired CO measurement, restitution, and outcome comment initiated no later than at the 24th week of amenorrhea and conducted thoughout the whole pregnancy.
Date of birth
Secondary Outcomes (5)
Impact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke.
Date of birth
Impact on the intention of breastfeeding on the date of birth
Date of birth
Predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compounds
Date of birth
Maternal expired CO on the day of birth
Date of birth
Determinants of smoking cessation on the day of birth
Date of birth
Study Arms (3)
Smoking pregnant woman withCO measurement
EXPERIMENTALSmoking pregnant woman without CO measurement
OTHERNon Smoking pregnant woman
OTHERInterventions
An expired CO measurement will be performed by BabyCO and the result will be returned to the smoking pregnant woman by the consultant.
The nature of the samples taken during the delivery are: * maternal blood, * cord blood * placenta fragment
Eligibility Criteria
You may qualify if:
- Group of smoking pregnant women (N = 600):
- Pregnant women declaring themselves smokers (at least one cigarette a day).
- Aged at least 18 years old.
- Consultant at Limoges University Hospital before the 24th week of amenorrhea.
- Desiring to be followed for their entire pregnancy at the Children's.
- Desiring to give birth at the Children's.
- Accepting to participate in the study
- Group of strictly non-smoking pregnant women (N = 50):
- Pregnant women :
- Declaring not to be a smoker (to have been totally weaned for more than one year and to have smoked less than 100 cigarettes in her lifetime) before the beginning of the current pregnancy, and
- Whose partner and family do not smoke, and
- Not significantly exposed to tobacco (in their professional environment in particular), and
- With a CO measurement expired \<3 ppm.
- Aged at least 18 years old.
- Consultant at Limoges University Hospital before the 24th SA.
- +2 more criteria
You may not qualify if:
- Group of smoking pregnant women (N = 600) :
- Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.
- Women unable to understand the objectives of the study and the constraints of the protocol.
- Group of strictly non-smoking pregnant women (N = 50) :
- Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.
- Women unable to understand the objectives of the study and the constraints of the protocol.
- Women with high blood pressure
- Diabetic woman
- Woman with hypothyroidism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital, Limoges
Limoges, 87042, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2019
First Posted
February 15, 2019
Study Start
March 18, 2019
Primary Completion
March 18, 2022
Study Completion
March 18, 2022
Last Updated
March 17, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share